// App-Quantinova.ai

: Sunitinib dose escalation after disease progression in metastatic renal cell carcinoma.

Researchers

Presenter

  • Jacques Raphael

Principal Investigators

  • Alia Thawer

  • Georg A. Bjarnason

Medical Centers

  • Department of Medicine, Division of Nephrology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, ON, Canada

  • Department of Pharmacy, Sunnybrook Odette Cancer Centre, Toronto, ON, Canada

  • Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Nephrology

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Sunitinib

Outcome

  • N/A

Study Design

  • Dose Escalation

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved